Henrik Hadimeri

886 total citations
32 papers, 564 citations indexed

About

Henrik Hadimeri is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Henrik Hadimeri has authored 32 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Henrik Hadimeri's work include Dialysis and Renal Disease Management (8 papers), Renal and Vascular Pathologies (8 papers) and Renal Diseases and Glomerulopathies (7 papers). Henrik Hadimeri is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Renal and Vascular Pathologies (8 papers) and Renal Diseases and Glomerulopathies (7 papers). Henrik Hadimeri collaborates with scholars based in Sweden, Netherlands and Denmark. Henrik Hadimeri's co-authors include G. Nyberg, Bernd Stegmayr, Carl Lamm, Björn Eliasson, Maria Svensson, Soffia Guðbjörnsdóttir, Gunnela Nordén, Björn Peters, Jan Cederholm and Johan Mölne and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Henrik Hadimeri

32 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Hadimeri Sweden 15 324 151 128 118 78 32 564
Audrey B. Tuttle United States 9 369 1.1× 88 0.6× 62 0.5× 126 1.1× 84 1.1× 10 637
Luigi Catizone Italy 15 385 1.2× 95 0.6× 172 1.3× 178 1.5× 43 0.6× 44 711
Richard Nissel Germany 14 363 1.1× 157 1.0× 125 1.0× 101 0.9× 174 2.2× 18 788
V. de Précigout France 16 422 1.3× 108 0.7× 110 0.9× 24 0.2× 30 0.4× 44 671
L Algranati Argentina 12 280 0.9× 124 0.8× 84 0.7× 35 0.3× 56 0.7× 24 430
Xiajing Che China 12 353 1.1× 94 0.6× 72 0.6× 14 0.1× 58 0.7× 43 591
J.-C. Terrat France 9 597 1.8× 70 0.5× 214 1.7× 104 0.9× 17 0.2× 10 673
Rita Birne Portugal 7 332 1.0× 124 0.8× 74 0.6× 28 0.2× 40 0.5× 26 459
Stefano De Pietro Italy 11 328 1.0× 81 0.5× 150 1.2× 15 0.1× 37 0.5× 21 607
Ramin Sam United States 14 193 0.6× 133 0.9× 135 1.1× 45 0.4× 65 0.8× 33 503

Countries citing papers authored by Henrik Hadimeri

Since Specialization
Citations

This map shows the geographic impact of Henrik Hadimeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Hadimeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Hadimeri more than expected).

Fields of papers citing papers by Henrik Hadimeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Hadimeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Hadimeri. The network helps show where Henrik Hadimeri may publish in the future.

Co-authorship network of co-authors of Henrik Hadimeri

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Hadimeri. A scholar is included among the top collaborators of Henrik Hadimeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Hadimeri. Henrik Hadimeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasic, Salmir, et al.. (2022). Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis. PLoS ONE. 17(1). e0262880–e0262880. 4 indexed citations
3.
Peters, Björn, et al.. (2020). Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN Case Reports. 9(2). 159–161. 6 indexed citations
4.
Peters, Björn, et al.. (2016). High Resistive Index in Transplant Kidneys Is a Possible Predictor for Biopsy Complications. Transplantation Proceedings. 48(8). 2714–2717. 5 indexed citations
5.
Graaff, Reindert, et al.. (2016). Skin Autofluorescence, a Measure of Cumulative Metabolic stress and Advanced Glycation End Products, shows seasonal variations in dialysis patients. 1 indexed citations
6.
Smedby, Örjan, et al.. (2015). Fistula Diameter Correlates with Echocardiographic Characteristics in Stable Hemodialysis Patients. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1(1). 3 indexed citations
7.
Peters, Björn, Bernd Stegmayr, Yvonne Andersson, Henrik Hadimeri, & Johan Mölne. (2015). Increased risk of renal biopsy complications in patients with IgA-nephritis. Clinical and Experimental Nephrology. 19(6). 1135–1141. 11 indexed citations
8.
Engels, Gerwin E., et al.. (2015). Comparing Changes in Plasma and Skin Autofluorescence in Low-Flux versus High-Flux Hemodialysis. The International Journal of Artificial Organs. 38(9). 488–493. 8 indexed citations
9.
Hultman, Per, et al.. (2013). Membranoproliferative Glomerulonephritis and Inflammatory Pseudotumour of the Spleen. Case Reports in Oncology. 6(1). 84–89. 1 indexed citations
10.
Hadimeri, Henrik, Lars G. Svensson, Anders Fernström, et al.. (2013). A fixed protocol for outpatient clinic routines in the care of patients with severe renal failure. Renal Failure. 35(6). 845–854. 2 indexed citations
11.
Peters, Björn, Yvonne Andersson, Bernd Stegmayr, et al.. (2013). A study of clinical complications and risk factors in 1001 native and transplant kidney biopsies in Sweden. Acta Radiologica. 55(7). 890–896. 36 indexed citations
12.
Miftaraj, Mervete, Ann‐Marie Svensson, Henrik Hadimeri, et al.. (2012). Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population. Journal of Diabetes and its Complications. 27(3). 229–234. 18 indexed citations
13.
Cederholm, Jan, et al.. (2010). Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR). Nephrology Dialysis Transplantation. 26(4). 1236–1243. 105 indexed citations
14.
Ahlmén, J, et al.. (2008). A new safety device for hemodialysis. Hemodialysis International. 12(2). 264–267. 25 indexed citations
15.
Bäckman, Lars, Lola Svensson, Ulf Strömbom, et al.. (2006). Steroid-Free Immunosuppression in Kidney Transplant Recipients and Prograf Monotherapy: An Interim Analysis of a Prospective Multicenter Trial. Transplantation Proceedings. 38(8). 2654–2656. 4 indexed citations
16.
Hadimeri, Henrik, et al.. (2003). Arteriovenous PTFE Dialysis Access in the Lower Extremity: A New Approach. Annals of Vascular Surgery. 17(5). 581–584. 21 indexed citations
17.
Hadimeri, Henrik, et al.. (2000). Dimensions of Arteriovenous Fistulas in Patients with Autosomal Dominant Polycystic Kidney Disease. ˜The œNephron journals/Nephron journals. 85(1). 50–53. 9 indexed citations
18.
Hadimeri, Henrik, Carl Lamm, & G. Nyberg. (1998). Coronary aneurysms in patients with autosomal dominant polycystic kidney disease.. Journal of the American Society of Nephrology. 9(5). 837–841. 53 indexed citations
19.
Hadimeri, Henrik, Gunnela Nordén, S. Friman, & G. Nyberg. (1997). Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrology Dialysis Transplantation. 12(7). 1431–1436. 51 indexed citations
20.
Hadimeri, Henrik, et al.. (1993). Inflammatory pseudotumour of the lung. Pediatric Radiology. 23(8). 624–625. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026